Huperzine A
Also known as: HupA, Hup A, selagine, Huperzia serrata extract
Effective Dosage
0.4–0.8 mg daily (clinical trial doses for cognitive/addiction studies)
What the Science Says
Huperzine A is a natural alkaloid extracted from the Chinese herb Huperzia serrata. It works by blocking acetylcholinesterase, the enzyme that breaks down acetylcholine — a brain chemical critical for memory and learning — which raises acetylcholine levels in the brain. Clinical studies show it can meaningfully improve cognitive function and task-switching ability in Alzheimer's patients, and it has been approved in China for AD treatment since 1996. Early research also suggests potential roles in seizure suppression and cocaine use disorder, though these applications need much more study.
What It Doesn't Do
Not proven to boost memory or focus in healthy people. No solid evidence it enhances athletic performance. Won't reverse Alzheimer's disease — it manages symptoms only. Not a substitute for FDA-approved dementia medications. No evidence it works as a general 'brain booster' for everyday use.
Evidence-Based Benefits
Huperzine A is a reversible acetylcholinesterase (AChE) inhibitor that increases acetylcholine availability in the brain, and has been clinically approved in China for Alzheimer's disease treatment since 1996 (PMID: 39637486). In a double-blind study of AD patients, 8 weeks of treatment significantly improved cognition and task-switching abilities compared to baseline (PMID: 30839402). Preclinical and pharmacokinetic data show it rapidly penetrates the brain, elevates acetylcholine across multiple brain regions, and may modulate monoamine neurotransmitters (PMID: 41781122). Animal studies also suggest potential for suppressing absence seizures (PMID: 39096485).
Moderate EvidenceEffective at: 0.4-0.8 mg daily (clinical trials); No established dose for healthy adults
Source: auto-research
Absorption & Bioavailability
Good — rapidly absorbed with demonstrated brain penetration in animal models; age significantly affects clearance in elderly patients, meaning older adults process it more slowly and may need dose adjustments.
Red Flags to Watch For
- Known side effects include nausea, dizziness, and digestive disorders — even at therapeutic doses
- Age significantly alters drug clearance; elderly users face higher exposure and greater side effect risk
- Widely sold as a nootropic supplement despite clinical evidence being almost entirely in Alzheimer's patients, not healthy adults
- Plant source (Huperzia serrata) is scarce; some products may use synthetic or microbially derived HupA of uncertain quality
- Can interact with other cholinergic drugs (e.g., donepezil, rivastigmine); combining them risks cholinergic toxicity
Products Containing Huperzine A
See how Huperzine A is used in these analyzed products:
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06